Expand CRVS Menu
CRVS MENU

CRVS Stock Posts


Unusual Option Volume

CRVS Corvus Pharmaceuticals26.52+1.00 (+3.9%)

Corvus Pharmaceuticals trades 1,668 contracts.
View Details...
Unusual Option Volume

CRVS Corvus Pharmaceuticals25.52+3.37 (+15.2%)

Corvus Pharmaceuticals trades 811 contracts. News: Corvus Pharmaceuticals Announces Pricing of Upsized Public Offering of Common Stock
View Details...
Unusual Option Volume

CRVS Corvus Pharmaceuticals22.21+0.80 (+3.7%)

Corvus Pharmaceuticals trades 4,931 contracts. News: Corvus Pharmaceuticals Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants
View Details...
CRVS #CorvusPharmaceuticals stock declines -5.9% in after hours trading. See the latest news.

After Hours Decliner

CRVS Corvus Pharmaceuticals21.41+13.36+166.0%

After Hours:20.15-1.26 (-5.9%)

Corvus Pharmaceuticals Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants

Globe NewswireTue, 20-Jan 4:01 PM
Unusual Option Volume

CRVS Corvus Pharmaceuticals14.97+6.92 (+86.0%)

Corvus Pharmaceuticals trades 13,759 contracts. The company has the following event: Conference Call and Webcast: Overview of Soquelitinib Atopic Dermatitis Cohort 4 Phase 1 Clinical Data on Jan 20, 2026. News: Corvus Pharmaceuticals Announces Positive Data from Cohort 4 Confirming Results for Placebo-Controlled Phase 1 Clinical Trial of Soquelitinib for Atopic Dermatitis
View Details...
CRVS #CorvusPharmaceuticals stock increases 3.1% after hours.

After Hours Gainer

CRVS Corvus Pharmaceuticals8.05+0.91+12.8%

After Hours:8.30+0.25 (+3.1%)

Corvus Pharmaceuticals to Announce Results from Cohort 4 of Placebo-Controlled Phase 1 Clinical Trial of Soquelitinib for Atopic Dermatitis

Globe NewswireFri, 16-Jan 4:01 PM
Load Earlier Posts
Market Data Delayed 15 Minutes